AI & Quality Measures
1 Room. 20 Programs. 100% Medicare Eligible.
AI & Quality Measures
AI-Driven Products & Services
DTC AI Care Clinics® are transforming rural healthcare by improving accessibility, efficiency, and quality measures in underserved areas. Two FDA-cleared AI devices and one AI billing service demonstrate how cutting-edge innovations can support rural clinics in delivering high-quality care:
DermaSensor for Skin Cancer Detection: This AI-powered tool offers rapid, non-invasive evaluations of suspicious skin lesions in seconds. Its compact design allows providers in rural areas to screen for skin cancer efficiently, expanding access to preventative care and early detection.
AI Handheld Fundus Camera: Designed for diabetic retinopathy management, this device provides accurate, autonomous diagnoses at the point of care in under 60 seconds. Fully reimbursable and requiring no dilation, it eliminates the need for referrals, streamlines clinic workflows, and ensures timely interventions for better patient outcomes. Its portability and ease of use make it an ideal solution for rural clinics striving to meet diabetic care quality benchmarks.
AI Billing Solutions: Designed to optimize reimbursements, reduce claim denials, and streamline revenue cycles for healthcare providers. Traditional billing methods often struggle with inefficiencies, human errors, and delays, leading to lost revenue and administrative burdens. With AI-powered billing services, medical providers can now experience a faster, more accurate, and highly adaptive approach to claims processing.
Both devices and our AI billing solutions exemplify the future of AI in healthcare, offering transformative solutions to enhance diagnostic accuracy, practice efficiency, and accessibility to high-quality care. Test Now, Know Now.
The DermaSensor™ device is an innovative FDA-cleared, AI-powered handheld device designed to empower primary care providers (PCPs) in the early detection of skin cancer. Each screening conducted with the device generates a clear, color-coded report, allowing PCPs to quickly and easily interpret the results for individual patients. The device also includes integrated software that tracks the number of screenings performed, complete with time stamps, ensuring accurate record-keeping and facilitating streamlined patient management.
It is well known that access to dermatologists for the diagnosis and treatment of skin cancer remains a significant challenge, with nearly 40% of the U.S. population living in areas where dermatologic care is limited or unavailable. This shortage disproportionately affects rural and underserved communities, leaving many patients without timely evaluation and increasing their risk of advanced disease. In this context, PCPs play a critical role in bridging the gap in care by serving as the first line of defense in detecting skin cancers early.
Early detection is essential for improving patient outcomes, as identifying skin malignancies at an initial stage significantly reduces morbidity and mortality. Additionally, it alleviates the financial burden on both patients and the healthcare system by preventing the high costs associated with late-stage treatments. By equipping PCPs with accessible, efficient, and accurate diagnostic tools like DermaSensor™, the healthcare system can empower providers to enhance skin cancer screening capabilities and deliver timely care to a broader population.
This groundbreaking technology not only improves diagnostic confidence but also increases access to early detection, particularly in areas with limited specialist availability. By enabling earlier interventions and reducing the need for unnecessary referrals, the DermaSensor™ device contributes to better patient outcomes and significant reductions in overall healthcare costs.
Skin Cancer Affects 1 in 5 Americans
The Optomed Aurora AEYE (AI) is the first FDA Cleared AI Fundus Camera. Our pioneering AI fundus camera combines the convenience of a no-start-up-cost model with the clinical excellence of a handheld device. Offering instant screening results directly on the camera display, it enables scalable revenue growth for healthcare providers without the need for fixed imaging setups or cumbersome PC installations, redefining the economics of high-quality diabetic retinopathy screening.
With unparalleled portability and adaptability, our solution sets a new standard in diabetic retinopathy screening that can be performed by any trained healthcare professional during routine patient exams. FDA-cleared and clinically validated, it delivers desktop image quality2 in a handheld device, enabling screenings anywhere and anytime. Our solution is here to close the care-gap and drive significant improvements in patient outcomes and healthcare ratings.
Experience the cutting-edge technology of the Optomed Aurora AEYE, revolutionizing eye care with its AI-powered capabilities. With high-quality imaging and a high-contrast optical design, this portable device ensures desktop image quality wherever you go. It is equipped with Smart Autofocus and Auto Exposure features and requires only one image per eye without dilation, allowing for easy exam process without compromising accuracy, making it the ultimate solution for efficient and effective diabetic retinopathy screening with results in less than 60 seconds. A fundus eye exam is critical to preventing and treating eye conditions that could potentially lead to vision loss like:
Diabetic retinopathy
High blood pressure
Macular degeneration
Retinal detachment
Glaucoma
Eye tumors
More than 2 in 5 Americans with diabetes have some stage of diabetic retinopathy
There are NO symptoms in the early stages of the disease
95% of vision loss can be prevented with early detection
50% of Americans with diabetes are not tested for Diabetic Retinopathy
AI-driven billing and coding solutions are revolutionizing healthcare administration, ensuring accuracy, efficiency, and financial optimization for medical practices. By leveraging advanced automation and intelligent algorithms, AI simplifies the complexities of medical billing, reduces errors, and accelerates reimbursement processes—allowing providers to focus on delivering quality patient care.
One of the most pressing challenges in healthcare today is billing inefficiencies and claim denials, which can lead to significant revenue loss and administrative burden. AI-powered billing solutions address these challenges by:
Automating Claims Processing – AI ensures proper coding, detects errors, and submits claims efficiently, reducing denials and improving cash flow.
Enhancing Compliance & Security – AI adapts to evolving regulations, maintaining HIPAA compliance while safeguarding patient data.
Optimizing Revenue Cycle Management – Real-time analytics provide insights into financial performance, helping practices maximize reimbursements and reduce delays in payments.
Streamlining Patient Billing – AI-powered systems generate clear, automated invoices and send payment reminders, enhancing patient experience and collection rates.
With nearly $262 billion lost annually due to inefficient medical billing processes, AI billing and coding solutions empower healthcare providers to recover lost revenue, improve efficiency, and reduce administrative workload. These cutting-edge technologies are particularly valuable for smaller practices, rural providers, and specialty clinics, ensuring that they can streamline operations, increase revenue, and deliver better patient care—all without the complexity of traditional billing systems.
By integrating AI-powered billing into healthcare workflows, providers can achieve faster payments, improved accuracy, and better financial health, setting a new standard for efficiency in medical practice management.
AI Billing: Resistance is futile. 😆
Who We Serve
We look for increased efficiency from frontline disease screening to the most discerning specialists. Our mission is to prevent blindness and cancers by improving access globally. We strive to become the world-leading provider of AI handheld tools with POC.
Annual retinal exams and cancer screenings are included in the NCQA HEDIS ratings program, the Medicare Advantage STAR quality rating program and Medicare quality rating programs. By offering diabetic patients an on-the-spot retinal exam as part of their routine visit, PCPs can potentially qualify for financial incentives under these programs. Patients no longer need to have their eyes dilated or make separate appointments with eye care specialists. With these services available in PCP offices, patients have a more convenient way to get their annual retinal exam performed.
We offer PCPs a turn-key solution that includes an easy to operate retinal camera and our skin cancer tool, training for your staff and diagnostic reports integrated with artificial intelligence (AI) for the detection in less than 60 seconds.
Greater focus on preventive medicine and early disease detection
Compliance with quality standards
Unlock HEDIS bonuses
Minimal impact on patient flow
As part of the value-based care framework, reimbursement is now tied directly to patient care. Proactive and preventative care, especially for chronic diseases such as diabetes has become a critical component for health systems and providers. As such, these organizations are directly accountable for improving patient outcomes and quality.
Make better use of clinical resources
Improve screening compliance rates
Measurable improvements in HEDIS quality measures
Reduce healthcare costs
Smarter AI Tools for Better Outcomes